Tekla Life Sciences Investors (HQL) Insider Trading
- $7,085,451.16
- $6,607,374.39
- Sept. 22, 2025
- Saba Capital Management, L.P.
| Trader Name | Date | Title | Amount | Price | Type | Total Value | 
|---|---|---|---|---|---|---|
| Sept. 22, 2025 | Major Shareholder | 41,623 | $14.14 | Sell | $588,549.22 | |
| Sept. 19, 2025 | Major Shareholder | 6,989 | $14.10 | Sell | $98,544.90 | |
| Sept. 18, 2025 | Major Shareholder | 40,208 | $14.07 | Sell | $565,726.56 | |
| Sept. 17, 2025 | Major Shareholder | 24,328 | $13.99 | Sell | $340,348.72 | |
| Sept. 16, 2025 | Major Shareholder | 2,026 | $13.99 | Sell | $28,343.74 | |
| Sept. 15, 2025 | Major Shareholder | 700 | $14.13 | Sell | $9,891.00 | |
| Sept. 11, 2025 | Major Shareholder | 15,116 | $14.28 | Sell | $215,856.48 | |
| Sept. 2, 2025 | Major Shareholder | 14,083 | $14.04 | Sell | $197,725.32 | |
| Aug. 29, 2025 | Major Shareholder | 23,723 | $13.89 | Sell | $329,512.47 | |
| Aug. 26, 2025 | Major Shareholder | 400 | $13.83 | Sell | $5,532.00 | |
| Aug. 21, 2025 | Major Shareholder | 10,710 | $14.07 | Sell | $150,689.70 | |
| May 20, 2025 | Major Shareholder | 11,419 | $12.71 | Sell | $145,135.49 | |
| May 15, 2025 | Major Shareholder | 23,729 | $12.08 | Sell | $286,646.32 | |
| May 14, 2025 | Major Shareholder | 600 | $12.04 | Sell | $7,224.00 | |
| May 13, 2025 | Major Shareholder | 730 | $12.28 | Sell | $8,964.40 | |
| May 7, 2025 | Major Shareholder | 1,366 | $12.19 | Sell | $16,651.54 | |
| April 17, 2025 | Major Shareholder | 9,144 | $11.78 | Sell | $107,716.32 | |
| April 14, 2025 | Major Shareholder | 15,400 | $11.67 | Sell | $179,718.00 | |
| April 10, 2025 | Major Shareholder | 30,156 | $11.14 | Sell | $335,937.84 | |
| April 4, 2025 | Major Shareholder | 6,889 | $11.57 | Sell | $79,705.73 | |
| April 2, 2025 | Major Shareholder | 29,102 | $12.28 | Sell | $357,372.56 | |
| March 31, 2025 | Major Shareholder | 48,623 | $12.58 | Sell | $611,677.34 | |
| March 27, 2025 | Major Shareholder | 32,922 | $13.01 | Sell | $428,315.22 | |
| Feb. 26, 2025 | Major Shareholder | 200 | $13.62 | Sell | $2,724.00 | |
| Feb. 12, 2025 | Major Shareholder | 36,536 | $13.75 | Sell | $502,370.00 | |
| Feb. 10, 2025 | Major Shareholder | 42,987 | $13.95 | Sell | $599,668.65 | |
| Feb. 3, 2025 | Major Shareholder | 1,846 | $14.03 | Sell | $25,899.38 | |
| Jan. 31, 2025 | Major Shareholder | 15,143 | $14.27 | Sell | $216,090.61 | |
| Jan. 29, 2025 | Major Shareholder | 11,674 | $14.12 | Sell | $164,836.88 | |
| Aug. 23, 2024 | Director | 650 | $15.37 | Buy | $9,990.50 | |
| July 16, 2024 | Director | 1,000 | $15.53 | Buy | $15,530.00 | |
| June 26, 2024 | Major Shareholder | 100 | $14.07 | Buy | $1,407.00 | |
| June 24, 2024 | Major Shareholder | 13,812 | $14.08 | Buy | $194,472.96 | |
| June 12, 2024 | Major Shareholder | 2,400 | $13.88 | Buy | $33,312.00 | |
| June 10, 2024 | Major Shareholder | 9,704 | $13.71 | Buy | $133,041.84 | |
| June 6, 2024 | Major Shareholder | 9,598 | $13.80 | Buy | $132,452.40 | |
| June 4, 2024 | Major Shareholder | 33,357 | $13.50 | Buy | $450,319.50 | |
| May 30, 2024 | Major Shareholder | 669 | $13.05 | Buy | $8,730.45 | |
| May 28, 2024 | Major Shareholder | 8,714 | $13.38 | Buy | $116,593.32 | |
| May 23, 2024 | Major Shareholder | 1,303 | $13.50 | Buy | $17,590.50 | |
| May 15, 2024 | Major Shareholder | 34,755 | $14.19 | Buy | $493,173.45 | |
| May 10, 2024 | Major Shareholder | 57,862 | $13.86 | Buy | $801,967.32 | |
| May 8, 2024 | Major Shareholder | 10,986 | $13.70 | Buy | $150,508.20 | |
| May 6, 2024 | Major Shareholder | 10,713 | $13.62 | Buy | $145,911.06 | |
| May 2, 2024 | Major Shareholder | 26,274 | $13.46 | Buy | $353,648.04 | |
| April 30, 2024 | Major Shareholder | 16,573 | $13.13 | Buy | $217,603.49 | |
| April 26, 2024 | Major Shareholder | 120,304 | $13.00 | Buy | $1,563,952.00 | |
| April 24, 2024 | Major Shareholder | 20,529 | $13.12 | Buy | $269,340.48 | |
| April 22, 2024 | Major Shareholder | 2,022 | $12.88 | Buy | $26,043.36 | |
| April 18, 2024 | Major Shareholder | 81,738 | $12.80 | Buy | $1,046,246.40 | 
- Insiders are both buying and selling Tekla Life Sciences Investors stock. 
- The insider traders at Tekla Life Sciences Investors are: Saba Capital Management, L.P., Daniel R Omstead, Kathleen Goetz, Thomas M Kent, Bill Maher, Todd Reit, Daniel R. Omstead, and Rose Dimartino 
- The most active insider trader at Tekla Life Sciences Investors is Saba Capital Management, L.P. with 48 trades. 
- Saba Capital Management, L.P. has sold the most Tekla Life Sciences Investors stock with a total value of $7,195,923.61. 
- Saba Capital Management, L.P. has bought the most Tekla Life Sciences Investors stock with a total value of $6,157,720.77. 
- The most recent insider trade for Tekla Life Sciences Investors was on Sept. 22, 2025. 
- The single biggest insider buy for Tekla Life Sciences Investors was from Saba Capital Management, L.P. with a total value of $1,563,952.00 on April 26, 2024. 
- The single biggest insider sell for Tekla Life Sciences Investors was from Saba Capital Management, L.P. with a total value of $611,677.34 on March 31, 2025. 
